We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

39 hedge funds and large institutions have $255M invested in Foghorn Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

1.55% more ownership

Funds ownership: 63.34% → 64.88% (+1.5%)

13% less funds holding

Funds holding: 45 → 39 (-6)

17% less capital invested

Capital invested by funds: $307M → $255M (-$51.6M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.68%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
3
Increased
20
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$7.21M
2
Morgan Stanley
Morgan Stanley
New York
+$6.39M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.01M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$993K
5
State Street
State Street
Massachusetts
+$875K

Top Sellers

1
CAM
Cormorant Asset Management
Massachusetts
-$13.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.44M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$1.29M
4
OCA
Octagon Capital Advisors
New York
-$911K
5
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$404K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$131K +$74.8K +6,861 +127%
FT
27
Fiduciary Trust
Massachusetts
$116K – – –
NC
28
NewSquare Capital
Pennsylvania
$53K +$54.5K +5,000 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$27K +$14.3K +1,309 +102%
Legal & General Group
30
Legal & General Group
United Kingdom
$18K +$11K +1,006 +141%
AIP
31
Ameritas Investment Partners
Nebraska
$16K +$10.2K +932 +155%
TRCT
32
Tower Research Capital (TRC)
New York
$15K -$6.19K -568 -29%
Citigroup
33
Citigroup
New York
$10K +$4.94K +453 +95%
CAL
34
Capital Analysts LLC
Pennsylvania
$6K – – –
RE
35
RBC Europe
United Kingdom
$1.49K – – –
S
36
SignatureFD
Georgia
$1K +$828 +76 New
AIG
37
American International Group
New York
$117 +$73.7K +6,768 +161%
CAM
38
Cormorant Asset Management
Massachusetts
– -$13.2M -1,000,000 Closed
Point72 Asset Management
39
Point72 Asset Management
Connecticut
– -$1.44M -109,200 Closed
PAMU
40
Pictet Asset Management (UK)
United Kingdom
– -$1.29M -98,085 Closed
OCA
41
Octagon Capital Advisors
New York
– -$911K -69,132 Closed
BOTOTLSJU
42
Board of Trustees of The Leland Stanford Junior University
California
– -$404K -30,657 Closed
Victory Capital Management
43
Victory Capital Management
Texas
– -$213K -16,190 Closed
Wells Fargo
44
Wells Fargo
California
– -$24.1K -2,213 -98%
UBS Group
45
UBS Group
Switzerland
– -$28K -2,136 Closed
TFM
46
TFC Financial Management
Massachusetts
– -$4K -280 Closed
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
– -$3K -222 Closed
1
2

FHTX Hedge Fund Activity: Q2 2021 in Review

39 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q2 2021, worth a combined $255M — down 17% from $307M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of FHTX and 3 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 20 added.

The largest buyer was BlackRock, adding an estimated $7.21M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $13.2M sold.

  • 39 institutional investors held Foghorn Therapeutics (FHTX) as of Q2 2021, down from 45 in Q1 2021.
  • Funds reported $255M of Foghorn Therapeutics stock for Q2 2021, down 17% quarter-over-quarter.
  • 3 funds opened new Foghorn Therapeutics positions in Q2 2021 and 9 closed out, a net change of -6 holders.
  • The largest Foghorn Therapeutics buyer in Q2 2021 was BlackRock, an estimated $7.21M added.
  • The largest Foghorn Therapeutics seller in Q2 2021 was Cormorant Asset Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q2 2021.